Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome.

Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2. Biophys J (2005) 1.02

Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch (2013) 1.02

Focus on Extracellular Vesicles: Introducing the Next Small Big Thing. Int J Mol Sci (2016) 0.96

Ca2+ promotes erythrocyte band 3 tyrosine phosphorylation via dissociation of phosphotyrosine phosphatase from band 3. Biochem J (2002) 0.95

Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells. Bioarchitecture (2014) 0.86

The influence of membrane physical properties on microvesicle release in human erythrocytes. PMC Biophys (2009) 0.83

Phospholipid scramblase 1 (PLSCR1) in villous trophoblast of the human placenta. Histochem Cell Biol (2014) 0.78

Binding of Alphaherpesvirus Glycoprotein H to Surface α4β1-Integrins Activates Calcium-Signaling Pathways and Induces Phosphatidylserine Exposure on the Plasma Membrane. MBio (2015) 0.76

Membrane properties involved in calcium-stimulated microparticle release from the plasma membranes of S49 lymphoma cells. ScientificWorldJournal (2014) 0.75

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet (1990) 6.54

Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet (1967) 5.38

The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta (1973) 3.83

The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66

Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest (1973) 2.94

Localization of red cell membrane constituents. Biochim Biophys Acta (1973) 2.88

Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest (1973) 2.71

Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med (1974) 2.44

Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim Biophys Acta (1975) 2.42

The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem (1980) 2.39

Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci (2005) 2.32

Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31

Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res (1978) 2.14

The enzymatic synthesis of phosphatidylserine and purification by CM-cellulose column chromatography. Biochim Biophys Acta (1977) 2.14

A lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterification in yeast. J Biol Chem (2000) 2.04

Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J Biol Chem (1998) 1.98

Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta (1999) 1.93

Transient arthritis after rubella vaccination. Am J Dis Child (1969) 1.86

Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med (1974) 1.86

Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest (1977) 1.85

Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta (1983) 1.74

Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med (1975) 1.69

Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63

Lipid-protein interactions in blood coagulation. Biochim Biophys Acta (1998) 1.62

Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography. Thromb Diath Haemorrh (1972) 1.61

Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem (1982) 1.61

Membrane asymmetry and blood coagulation. Nature (1977) 1.57

Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost (1991) 1.55

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta (1986) 1.53

Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases. Biochim Biophys Acta (1975) 1.53

Secretable storage pools in platelets. Annu Rev Med (1979) 1.49

Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science (1973) 1.49

Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47

Aspirin--a dangerous drug? JAMA (1974) 1.47

Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med (1978) 1.46

Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med (1971) 1.46

Lytic and non-lytic degradation of phospholipids in mammalian erythrocytes by pure phospholipases. Biochim Biophys Acta (1973) 1.45

Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood (1979) 1.45

Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci U S A (1995) 1.42

Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol (1993) 1.42

Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood (1978) 1.39

Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38

Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood (1997) 1.38

Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet (1990) 1.38

Complete purification and some properties of phospholipase C from Bacillus cereus. Biochim Biophys Acta (1971) 1.35

Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta (1990) 1.34

Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta (1991) 1.33

Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33

Subcellular localization of the enzymes of cholesterol biosynthesis and metabolism in rat liver. J Biol Chem (1987) 1.33

Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta (1977) 1.31

Human acyl-CoA:diacylglycerol acyltransferase is a tetrameric protein. Biochem J (2001) 1.30

Topological asymmetry of phospholipid metabolism in rat erythrocyte membranes. Evidence for flip-flop of lecithin. Eur J Biochem (1976) 1.29

Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood (1991) 1.28

Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein. J Biol Chem (1998) 1.26

Freeze-fracture appearance and disposition of band 3 protein from the human erythrocyte membrane in lipid vesicles. Eur J Biochem (1978) 1.26

Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26

The solubilization of human erythrocyte membranes by n-pentanol. Biochim Biophys Acta (1968) 1.25

Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med (1972) 1.25

Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med (1968) 1.24

Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23

Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23

Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood (1986) 1.21

Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest (1984) 1.20

Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry (1996) 1.19

The role of activated human platelets in prothrombin and factor X activation. Blood (1985) 1.19

Interactions between proteins and lipids from human red cell membranes. Chem Phys Lipids (1970) 1.19

A familialdefect in platelet function associated with imapired release of adenosine diphosphate. N Engl J Med (1969) 1.18

Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem (1986) 1.17

Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17

A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17

Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med (1967) 1.16

Phospholipid scramblase activation pathways in lymphocytes. Biochemistry (2001) 1.15

Isolated deficiency of platelet procoagulant activity. Am J Med (1979) 1.15

Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry (1995) 1.15